Asia · Markets & Finance · Vietnam Investment Review

Translumina launches SPARX global trial for drug-coated coronary balloons

Published by Vietnam Investment Review · Vietnam 11 h ago

Medical device company Translumina initiated the multinational SPARX randomized controlled trial to evaluate drug-coated balloon treatment strategies against conventional…

Read the full article on Vietnam Investment Review Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (vir.com.vn)

Also worth reading

Mint

Capital goods stocks fall after multibagger rally. Is this a buying opportunity for long-term investors?

The Economic Times

Translumina launches SPARX global trial for drug-coated coronary balloons

Share

Also worth reading

Capital goods stocks fall after multibagger rally. Is this a buying opportunity for long-term investors?

Let rupee find its own level: Uday Kotak

‘Brutal session’ for chip stocks shows AI trade is turning

IMDA expands digital support for SMEs

BOJ to lean against back-to-back rate hike in October — Bloomberg

Foreign varsities' India campuses unlikely to strengthen research